• Tidak ada hasil yang ditemukan

BAB V KESIMPULAN DAN SARAN

B. Saran

1. Perlu dilakukan validasi retrospektif terhadap protokol yang digunakan untuk

memperkuat dugaan aktivitas 2-(4’-hidroksi-3’-metoksibenzilidena)

sikloheksana-1,3-dion terhadap protein NF-κB.

2. Perlu dilakukan uji aktivitas senyawa 2-(4’-hidroksi-3’-metoksibenzilidena) sikloheksana-1,3-dion terhadap protein NF-κB secara invitro.

DAFTAR PUSTAKA

Anonim, 2001, Merck Index 13th: An Encyclopedia of Chemicals, drugs and

biological, Merck & Co., Inc., USA, p. 559.

Anonim, 2003, Kanker Penyebab Kematian Keenam Terbesar di Indonesia,

http://www.depkes.go.id/index.php/berita/info-umum-kesehatan/539-

kanker-penyebab-kematian-keenam-terbesar-di-indonesia.html, diakses pada tanggal 20 Februari 2012.

Anonim, 2012, Cancer: Fact Sheets, http://www.who.int/mediacentre/

factsheets/fs297/en/index.html, diakses pada tanggal 18 Februari 2012. Atkins, P.W., Jones, dan Loretta, 2010, Chemical Principles: The Quest for Insight,

5th edition, W. H. Freeman, New York, p. 459.

Bhagat, S., Sharma R. and Chakraborti A.K., 2006., Dual-activation protocol for tandem cross-aldol condensation: an easy and highly efficient synthesis of

α,ά-bis(aryl/alkylmethylidene)ketones. J. Mol. Catal.A: Chem., 260, 235- 240.

Bradstatter, M.K., 1971, Thermomicroscopy’s Analysis of Pharmaceutical,

Pergamon Press, London, 1-10.

Bresnick, S.D., 2004, Intisari Kimia Organik, Penerbit Hipokrates, Jakarta, pp. 96- 97, 101-107.

Christy, A. M., 2010, Sintesis Senyawa 2-(4’-klorobenzilidena) sikloheksanadion

dari 1,3-Sikloheksanadion dan 4-Klorobenzaldehid dengan Katalis Kalium Hidroksida, Skripsi, Program Sarjana Fakultas Farmasi Universitas Sanata Dharma, Yogyakarta.

Cvek, E. dan Dvorak Z., 2007, Targeting of nuclear factor NF- B amd proteasome

by dithiocarbamate complexes with metals, Curr. Pharm. Des., 13 (30): 3155-3167.

de Leon-Boenig, G., Bowman, K.K., Feng, J.A., Crawford, T., Everett, C., Franke, Y., et al., 2012, The crystal structure of the catalytic domain of the NF- B inducing kinase reveals a narrow but flexible active site, Structure, 20(10), 1704-1714.

Direktorat Jenderal Pengawasan Obat dan Makanan RI, 1979, Farmakope

Direktorat Jenderal Pengawasan Obat dan Makanan RI, 1995, Farmakope Indonesia, jilid IV, Departemen Kesehatan RI, Jakarta, 1.

Escárcega, R.O., Fuentes A.S., García C.M., Gatica A., and Zamora A., 2007, The transcription factor nuclear factor- B and cancer, Clinical Oncology, 19 (2): 154–161.

Ettre, L.S., 1993, Nomenclature for chromatography (IUPAC Recommendations

1993), Pure and Appl. Chem., 65 (4): 839-845.

Gandjar, I.G. dan Rohman, A., 2007, Kimia Farmasi Analisis, Pustaka Pelajar, Yogyakarta, 328, 353, 355, 366-367, 419-420.

Hamdy, N.A., 2008, Denosumab: RANKL inhibition in the management of bone loss, Drugs Today (Barc)., 44 (1): 7-21.

Harwood, L.M. dan Moody, C.J., 1989, Experimental organic chemistry:

Principles and Practice, John Wiley & Sons, Limited, Canada, pp. 159–173. Istyastono, E. P., Yuniarti, N., Jumina, 2009, Sintesis Senyawa Berpotensi sebagai

Inhibitor Angiogenesis : 2-benzilidenasikloheksana-1,3-dion, Majalah

Farmasi Indonesia, 20(1-8).

Istyastono, E.P., 2010, Seri Kimia Medisinal Komputasi: Langkah Praktis Docking

Gratis, Penerbit MOLMOD.ORG, Yogyakarta, 7.

Jenkins, G.L., Knevel, A.M. dan Digangi, F.E., 1965, Quantitative Pharmaceutical

Chemistry, 6th Edition, McGraw-Hill Book Company, New York.

Korb, O., Stützle, T. dan Exner, T.E., 2006, PLANTS: Application of Ant Colony Optimization to Structure-Based Drug Design. In Ant Colony Optimization and Swarm Intelligence, 5th International Workshop, Brussels, Belgium, 4-7 September, 2006, 247-258.

Korb, O., Stützle, T. dan Exner, T.E., 2009, Empirical Scoring Functions for

Advanced Protein-Ligand Docking with PLANTS, J. Chem. Inf. Model., 49:

84–96.

Korb, O. dan Exner, T., 2012, PLANTS, Protein-Ligand ANT System: user manual

for version 1.2, http://www.tcd.uni-konstanz.de/plants_download/download /manual1.2.pdf.

Krieger, E., Koraimann, G., dan Vriend, G.,2002, Increasing the precision of

comparative models with YASARA NOVA a self parameterizing force field, Proteins, 47, 393-402.

Larson, R.S., 2006, Methods in molecular biology: Bioinformatics and Drug Discovery, Humana Press Inc., Totowa, New Jersey.

Leach, A.R., 2001, Molecular Modelling: Principles and Applications, Prentice- Hall, Inc., Englewood Cliffs, New Jersey.

Lee C.H., Jeon Y.T., Kim S.H., and Song Y.S.. 2007, NF- B as a potential molecular target for cancer therapy, BioFactors, 29: 19-35.

MacKenzie, 1967, Experimental Organic Chemistry, 3th Edition, Prentice-Hall, Inc., Englewood Cliffs, New Jersey.

Oxtoby, D.W., Gillis, H.P., dan Nachtrieb, N.H., 2001, Prinsip-Prinsip Kimia Modern, 4th, jilid 1, diterjemahkan oleh Akhmadi, Suminar Setiati, Penerbit Erlangga, Jakarta, 439-441.

Palleros, D.R., 2004, Solvent-Free Synthesis of Chalcones, J. Chem. Educ., 81(9),

1345-1347.

Paul, A.G., 2005, NF-κB: A Novel Therapeutic Target for Cancer, Eukaryon. 1: 4- 5.

Reksohadiprodjo, M.S., 1996, Kuliah dan Praktika Kimia Farmasi Preparatif, seri

Kimia Fisik Organik, Fakultas Farmasi UGM, Yogyakarta, 7-12.

Rowe, R.C., Sheskey, P.J. dan Quinn, M.E., 2009, Handbook of

Pharmaceutical Excipients, 6th, Pharmaceuticals Press, London, UK, pp. 760- 761.

Sastrohamidjojo, H., 2001, Spektroskopi, edisi kedua, Liberty, Yogyakarta, 71-96. Setiawati, M.I., 2012, Sintesis Senyawa 2-(4’-hidroksibenzilidena) sikloheksana-

1,3-dion dari Sikloheksana-1,3-dion dan 4-Hidroksibenzaldehid dengan

Katalis Kalium Hidroksida, Skripsi, Program Sarjana Fakultas Farmasi

Universitas Sanata Dharma, Yogyakarta.

Silverstein, R.M., Webster, F.X. dan Kiemle, D.J., 2005, Spectrometric

Identification of Organic Compounds, 7th edition, John Wiley & Sons, Inc., USA, p. 94.

Surh, Y.J, 2008, NF- B and Nrf2 as potential chemopreventive targets of some anti-

inflammatory and antioxidative phytonutrients with anti-inflammatory and antioxidative activities, Asia Pac J Clin Nutr., 17(S1), 269-272.

Tro, N.J., 2011, Chemistry A Molecular Approach, 2nd edition, Prentice-Hall, Inc., USA, pp. 581-583.

Tureček, F. dan McLafferty, F.W., 1993, Interpretation of mass spectra, University Science Books, United Kingdom, p. 290.

Watson, D.G., 2009, Buku Ajar untuk Mahasiswa Farmasi dan Praktisi Kimia

Farmasi, edisi 2, Winny R. Syarief, Penerbit Buku Kedokteran EGC, Jakarta, 135-136, 223-225.

Weber W.M., Hunsaker L.A., Roybal C.N., Marjon E.V.B., Abcouwer S.F., Royer R.E., et al., 2006, Activation of NF- B is inhibited by curcumin and related

LAMPIRAN

Lampiran 1. Data Penimbangan StartingMaterial dan Perhitungan Massa Senyawa Hasil Sintesis Secara Teoritis

REPLIKASI I

sikloheksana-1,3-dion 4-hidroksi-3-metoksibenzaldehida kalium hidroksida Berat wadah 0,418 gram 0,408 gram 15,377 gram Berat wadah + zat 0,872 gram 1,046 gram 15,783 gram Berat wadah + sisa 0,421 gram 0,412 gram 15,382 gram Berat zat 0,451 gram 0,634 gram 10,401 gram Jumlah dalam mmol 4,027 mmol 4,171 mmol 07,035 mmol

HO O O H H 3C + O O HO O O O H 3C

4-hidroksi-3-metoksibenzaldehida sikloheksana-1,3-dion 2-(4’-hidroksi-3’-metoksibenzilidena)sikloheksana- 1,3-dion

mula-mula : - 4,171 mmol - 4,027 mmol - bereaksi : - 4,027 mmol - 4,027 mmol + 4,027 mmol sisa : - 0,144 mmol 0 + 4,027 mmol

mol produk yang diperoleh = 4,027 mmol

massa produk yang diperoleh secara teoritis = 4,027 mmol x 246 g/ mol = 990,642 mg

REPLIKASI II

sikloheksana-1,3-dion 4-hidroksi-3-metoksibenzaldehida kalium hidroksida Berat wadah 0,399 gram 0,407 gram 15,377 gram Berat wadah + zat 0,853 gram 1,020 gram 15,737 gram Berat wadah + sisa 0,404 gram 0,413 gram 15,345 gram Berat zat 0,449 gram 0,607 gram 10,392 gram Jumlah dalam mmol 4,009 mmol 3,993 mmol 06,877 mmol

KOH -H2O

HO O O H H 3C + O O HO O O O H 3C

4-hidroksi-3-metoksibenzaldehida sikloheksana-1,3-dion 2-(4’-hidroksi-3’-metoksibenzilidena)sikloheksana- 1,3-dion

mula-mula : - - 3,993 mmol - 4,009 mmol - bereaksi : - 3,993 mmol - 3,993 mmol + 3,993 mmol sisa : 0 - 0,016 mmol + 3,993 mmol

mol produk yang diperoleh = 3,993 mmol

massa produk yang diperoleh secara teoritis = 3,993 mmol x 246 g/ mol = 982,278 mg

REPLIKASI III

sikloheksana-1,3-dion 4-hidroksi-3-metoksibenzaldehida kalium hidroksida Berat wadah 0,218 gram 0,216 gram 15,340 gram Berat wadah + zat 0,678 gram 0,896 gram 15,737 gram Berat wadah + sisa 0,221 gram 0,219 gram 15,345 gram Berat zat 0,457 gram 0,677 gram 10,392 gram Jumlah dalam mmol 4,080 mmol 4,454 mmol 06,877 mmol

HO O O H H 3C + O O HO O O O H 3C

4-hidroksi-3-metoksibenzaldehida sikloheksana-1,3-dion 2-(4’-hidroksi-3’-metoksibenzilidena)sikloheksana- 1,3-dion

mula-mula : - 4,454 mmol - 4,080 mmol - bereaksi : - 4,080 mmol - 4,080 mmol + 4,080 mmol sisa : - 0,374 mmol 0 + 4,080 mmol

mol produk yang diperoleh = 4,080 mmol

massa produk yang diperoleh secara teoritis = 4,080 mmol x 246 g/ mol = 1003,68 mg

KOH -H2O

KOH -H2O

Lampiran 2. Data Penimbangan Crude Product dan Perhitungan Rendemen

Dokumen terkait